Bamco Inc Rocket Pharmaceuticals, Inc. Transaction History

Bamco Inc

$36.8 Billion
Q3 2024

A detailed history of Bamco Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Bamco Inc holds 884,341 shares of RCKT stock, worth $10 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

884,341

Previous 979,331 9.7%

Holding current value

$10 Million

Previous $21.1 Million 22.53%

% of portfolio

0.04%

Previous 0.06%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.6 - $25.88 $1.67 Million - $2.46 Million	-94,990 Reduced 9.7%	884,341 $16.3 Million
Q2 2024 Aug 14, 2024	SELL	$20.66 - $26.72 $231,660 - $299,611	-11,213 Reduced 1.13%	979,331 $21.1 Million
Q1 2024 May 15, 2024	SELL	$26.16 - $30.74 $1.62 Million - $1.9 Million	-61,957 Reduced 5.89%	990,544 $26.7 Million
Q4 2023 Feb 14, 2024	SELL	$16.78 - $31.94 $931,558 - $1.77 Million	-55,516 Reduced 5.01%	1,052,501 $31.5 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $3.39 Million - $5.42 Million	225,231 Added 25.51%	1,108,017 $22.7 Million
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $595,581 - $847,240	35,900 Added 4.24%	882,786 $17.5 Million
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $5.12 Million - $7.33 Million	324,541 Added 62.13%	846,886 $14.5 Million
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $7.79 Million - $11.4 Million	502,345 Added 2511.73%	522,345 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $247,399 - $368,200	20,000 New	20,000 $319,000

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $859M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account